Inflammatory breast cancer:vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model[J].Breast Cancer Research,2003,(03):136-139.Shirakawa K,Kobayashi H,Sobajima J.Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer ...
7. Dawood S, Broglio K, Gong Y, et al, for the Inflammatory Breast Cancer Research Group: Prognostic significance of HER-2 status in women with inflammatory breast cancer. Cancer 112:1905-1911, 2008.8. Dawood S, Gonzalez-Angulo AM, Broglio K, et al: HER-2 positive inflammatory breast...
Inflammatory breast cancer (IBC) is a rare and aggressive subtype of locally advanced breast cancer (LABC). Its diagnosis is primarily clinical; however, a pathological confirmation of invasive cancer is required. Historically, IBC was a uniformly fatal disease. A major advance in the last three...
Breast cancer patients have an increased risk of cardiometabolic disease and for many patients, adjuvant therapy causes an altered lipid profile, insulin resistance and inflammation. Previous follow-up studies are inconclusive regarding the duration of therapy-induced inflammation. We examined the acute an...
New research indicates that among individuals with breast cancer, those with a rare subtype called inflammatory breast cancer face a higher risk that their cancer will spread, or metastasize, to the brain. The study is published online in the Cancer jour
Kaempferol with Verapamil impeded panoramic chemoevasion pathways in breast cancer through ROS overproduction and disruption of lysosomal biogenesis... SK Nandi,N Chatterjee,T Roychowdhury,... - 《Phytomedicine》 被引量: 0发表: 2023年 Toward a New Generation of Bio-Scaffolds for Neural Tissue Engine...
5Giordano SH, Hortobagyi GN. Inflammatory Breast Cancer: Clinical Progress and the Main Problems that Must be Addressed.Breast Cancer Research.2003;5:284-288. 6Cristofanilli M, Boussen H, Baselga J, et al. A Phase II combination study of lapatinib and paclitaxel as a neoadjuvant therapy in...
Inflammatory breast cancer (IBC) is a rare and aggressive disease that accounts for ~2-4% of all breast cancers. However, despite its low incidence rate, IBC is responsible for 7-10% of breast cancer-related mortality in Western countries. Thus, the discovery of robust biological targets and...
Inflammatory Breast Cancer (IBC) is a highly aggressive malignancy with distinct clinical and histopathological features whose molecular basis is unresolved. Here we describe a human IBC cell line, A3250, that recapitulates key IBC features in a mouse xenograft model, including skin erythema, diffuse...
Research has found some unique risk factors for IBC. Still, researchers don't know why some people develop IBC. Family history may play a more minor role in IBC than other types of breast cancer, according to a study published in 2016 inBMC Cancer.6 ...